Lin J, Ji Y, Wang G, Ma X, et al. Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial. Atherosclerosis 2025;403:119120.
PMID: 39999660